Show heart failure rates in diabetes trials: experts Endocrinology Update Heart failure is almost universally ignored in large-scale diabetes trials even though some glucose-lowering drugs unequivocally raise the risk, experts report this week in the Lancet. Although regulatory bodies require proof of cardiovascular safety ... |
